The Efficacy of the Alma Hybrid System for a New Approach of Facial Skin Treatment

Rejuvenation Clinical Trial

Official title:
Prospective, Single-Center, Open-Label Study to Evaluate the Efficacy of the Alma Hybrid System for New Approach of Facial Skin Treatment With Minimal Downtime

Status Completed

Clinical Trial Summary

The study is aimed to evaluate the efficacy of the Alma Hybrid system for a new approach of facial skin treatment, using both ablative and non-ablative wavelengths. The study will include 20 subjects with mild-moderate photodamaged skin, that will undergo 2 facial skin treatments. Follow up visit to evaluate the efficacy of the treatments will take place 1 and 3 months after the last treatment.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Rejuvenation

Clinical Trial Details

NCT number	NCT04640207
Study type	Interventional
Source	Alma Lasers
Contact
Status	Completed
Phase	N/A
Start date	November 25, 2020
Completion date	July 18, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02910492` - Study of a Novel Laser for Skin Rejuvenation	N/A
Completed	`NCT05840445` - Efficacy of Prabotulinum and Onabotulinum Toxin-A for Facial Wrinkles	Phase 4
Active, not recruiting	`NCT05694286` - A Prospective Evaluation of Infraorbital Filler Injection	N/A
Completed	`NCT01403597` - Evaluation of Non-ablative and Fractional Combination Treatment for Improvement in Skin's Appearance	N/A
Enrolling by invitation	`NCT03767972` - Energy Devices for Rejuvenation	N/A
Completed	`NCT03189082` - Microbotox for Lower Face Rejuvenation	N/A